// App-Quantinova.ai

PO0590 : Development of a CKD Model in Cynomolgus Monkeys and Its Application to Test Zampilimab, a Monoclonal Antibody (mAb) Specific for Human Transglutaminase 2 (TG2)

Researchers

Presenter

  • Huang Linghong

Principal Investigators

  • Song JamesZhizhan

  • Johnson TimothyScott

Medical Centers

  • UCB Pharma, Slough, UK Slough United Kingdom

  • Prisys Biotechnology Shanghai China

Locations

  • United Kingdom

  • China

Companies

  • N/A

Study Components

Therapeutic Area

  • Nephrology

Disease

  • Kidney fibrosis

Biomarkers

  • Tissue transglutaminase

  • Transglutaminase 2

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved